Morgan Stanley said in a latest research report that Ping An Healthcare and Technology (Ping An Good Doctor, 1833.HK) is building a distinct competitive moat by integrating medical, health and elderly-care services with deep AI adoption, supported by the vast customer base and diversified resources of its parent, Ping An Group. The bank noted the company’s strong data foundation, including more than 1.44 billion structured consultation records and access to claims and health profiles of roughly 250 million financial customers, which provide high-quality training data for vertical medical large language models. In the first half of 2025, AI deployment reduced the average service cost per family doctor user by around 52% while maintaining a diagnostic accuracy rate of about 98%. The integration of its self-developed ‘Ping An MedGPT’ with DeepSeek has further strengthened service efficiency and cost advantages, underpinning the launch of the real-doctor digital avatar ‘Ping An Xin Yi’ for instant online consultations.
Looking ahead, Ping An Good Doctor expects its financial ecosystem business (F-end) to sustain growth of 10% to low double digits over the next three to five years, driven by deeper penetration into Ping An Group’s personal customer base. Its enterprise health management business (B-end) has emerged as a new growth engine, with projected expansion of 30% to 50% over the same period. Morgan Stanley said the company is exiting low-margin segments and focusing on higher-value clinical services and enterprise solutions, with AI driving cost efficiency across operations. The bank forecasts that Ping An Good Doctor’s mid-term revenue CAGR could surpass 10%, while net profit margin may rise steadily from an estimated 5–6% in 2025 to 10% or higher.
